Description
Patient Assistance Programs
Program Overview:Â ROCHE PRODUCTS INDIA PVT LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Alecensa 150mg Capsule. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits:Â Purchase 1 box of Alecensa 150mg Capsule, and you will receive 3 free additional boxes. Therefore, if eligible, you will have to pay only Rs. 1,17,159 for four boxes, which is Rs. 29,290 per box.
With MrMed’s MRP discount of Rs. 7448 per box and Roche’s PAP program, the overall savings is over Rs. 3.8 lakhs per purchase. Contact us for the latest updates on this exclusive offer.
Eligibility Criteria:Â To qualify for the Alecensa Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Alectinib 150mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at support@mrmed.in.
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Roche can avail of it without having to purchase the medication from MrMed.
Introduction to Alecensa 150mg Capsule
Alecensa 150mg Capsule consists of the active ingredient Alectinib Hydrochloride. It is an Anti-Cancer medication used to treat Non-small cell lung cancer (NSCLC), an advanced and spreading type of lung cancer. It effectively treats NSCLC that has spread to other body parts, including the brain. Alecensa 150mg Capsule is also generally well-tolerated and has fewer side effects than traditional chemotherapy. This can improve a person’s quality of life during treatment and allow them to continue with daily activities.
Inform your doctor before starting treatment if you are using oral contraceptives, as this medication might reduce the effect of the contraceptive. Let your doctor know if you have problems with the stomach, intestine, abdomen, heart, or lung inflammation problems or are lactose intolerant. Application of sun protection is essential while using Alecensa 150mg Capsule and must be continued up to 7 days after stopping its use, as this medication causes sunlight sensitivity. Consumption of grapefruit and Seville oranges should be done with caution as they reduce the effect of the medication.
Uses of Alecensa 150mg Capsule
Alecensa 150mg Capsule is been approved for the following conditions:
- To treat ALK-positive lung cancer (NSCLC) that has spread to other organs.
Therapeutic Effects of Alecensa 150mg Capsule
The therapeutic effects of Alecensa 150mg Capsule are related to its ability to target a specific genetic mutation called anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) cells. By inhibiting the ALK protein, this medication can slow down or stop the growth and spread of cancer cells that have the ALK genetic mutation.
Interaction of Alecensa 150mg Capsule with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Alecensa 150mg Capsule and reduce effectiveness by causing undesirable side effects.
Reviews
There are no reviews yet.